|
KLHDC4 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.0321999999946E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.758440E-04 |
| Normal-vs-Stage2 |
6.563700E-02 |
| Normal-vs-Stage3 |
1.243950E-03 |
| Normal-vs-Stage4 |
1.841550E-02 |
| Stage1-vs-Stage2 |
6.553800E-01 |
| Stage1-vs-Stage3 |
8.650400E-01 |
| Stage1-vs-Stage4 |
9.557200E-01 |
| Stage2-vs-Stage3 |
6.128200E-01 |
| Stage2-vs-Stage4 |
7.141800E-01 |
| Stage3-vs-Stage4 |
9.493800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.983600E-04 |
| Normal-vs-AfricanAmerican |
1.124910E-03 |
| Normal-vs-Asian |
1.92712000000039E-05 |
| Caucasian-vs-AfricanAmerican |
7.176000E-03 |
| Caucasian-vs-Asian |
2.451700E-02 |
| AfricanAmerican-vs-Asian |
4.313000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.171900E-04 |
| Normal-vs-Female |
2.166200E-04 |
| Male-vs-Female |
3.823000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.439800E-04 |
| Normal-vs-Age(41-60Yrs) |
5.624600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.324400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.244300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.046000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.438800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.443400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.847200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.979600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.215200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.630200E-01 |
| Classical-VS-Follicular |
4.995000E-01 |
| Classical-VS-Other |
6.205200E-01 |
| Classical-VS-Normal |
1.243140E-04 |
| Tall-VS-Follicular |
4.417000E-01 |
| Tall-VS-Other |
4.139200E-01 |
| Tall-VS-Normal |
2.543300E-03 |
| Follicular-VS-Other |
7.920800E-01 |
| Follicular-VS-Normal |
7.296400E-02 |
| Other-VS-Normal |
3.059200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.048400E-04 |
| Normal-vs-N1 |
1.815920E-02 |
| N0-vs-N1 |
9.107000E-01 |
|
|
